Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet

Reuters2021-02-19

Feb 18 (Reuters) - The first dose of Pfizer Inc and BioNTech's COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet

medical journal has found.

The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.

Overall infections, including among asymptomatic patients, were reduced by 75%.

Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.

The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated.

(Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)

((Derek.francis@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

JeremiahWoon
2021-02-19
JeremiahWoon
But why is Pfizer stock price still zzzz.. sigh
- JeremiahWoon:
  Haiz

Leave a comment

1

4

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2112897040?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-02-19 08:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2112897040","market":"us","top_or_hot":-1,"title":"Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet","media":"Reuters","content":"<html><body><p>Feb 18 (Reuters) - The first dose of Pfizer Inc    and BioNTech's    COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet </p><p>medical journal has found.</p><p>   The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.</p><p>   Overall infections, including among asymptomatic patients, were reduced by 75%.</p><p>   Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.</p><p>   The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated.</p><p> (Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)</p><p>((Derek.francis@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Study in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStudy in Israel shows Pfizer vaccine 85% effective after first dose - The Lancet\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-19 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Feb 18 (Reuters) - The first dose of Pfizer Inc    and BioNTech's    COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet medical journal has found.   The ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2112897040","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2112897040","pubTimestamp":1613695655,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Feb 18 (Reuters) - The first dose of Pfizer Inc    and BioNTech's    COVID-19 vaccine is 85% effecti","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"以色列的一项研究显示，辉瑞疫苗--柳叶刀--首次注射后有85%的效果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"Feb 18 (Reuters) - The first dose of Pfizer Inc    and BioNTech's    COVID-19 vaccine is 85% effective, a study of Israeli healthcare workers published in The Lancet medical journal has found.   The research was conducted on more than 7,000 healthcare workers who were vaccinated at the Sheba Medical Centre in Israel. Researchers saw an 85% reduction of symptomatic COVID-19 between 15 and 28 days after they were given the vaccine.   Overall infections, including among asymptomatic patients, were reduced by 75%.   Pfizer in an emailed statement said it was looking at real world data from Israel and other locations to understand the impact of its vaccine against COVID-19 arising from emerging variants.   The Lancet publication comes a day after Canadian researchers suggested that the second Pfizer dose be delayed given the high level of protection from the first shot in order to increase the number of people getting vaccinated. (Reporting by Derek Francis in Bengaluru; Editing by Jacqueline Wong)((Derek.francis@thomsonreuters.com))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":387009876,"gmtCreate":1613696021495,"gmtModify":1704883742674,"author":{"id":"3570311016208932","authorId":"3570311016208932","name":"JeremiahWoon","avatar":"https://static.tigerbbs.com/f9ff9fdefc613c6f5a4c8cd0c74ea082","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3570311016208932","authorIdStr":"3570311016208932"},"htmlText":"But why is Pfizer stock price&nbsp;still zzzz.. sigh","listText":"But why is Pfizer stock price&nbsp;still zzzz.. sigh","text":"But why is Pfizer stock price still zzzz.. sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/387009876","repostId":2112897040,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3620113,"gmtCreate":1613815020473,"gmtModify":1680777679928,"authorId":3570311016208932,"author":{"id":3570311016208932,"idStr":"3570311016208932","authorId":3570311016208932,"name":"JeremiahWoon","avatar":"https://static.tigerbbs.com/f9ff9fdefc613c6f5a4c8cd0c74ea082","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":387009876,"type":1,"supId":0,"prevId":0,"content":"Haiz","text":"Haiz","html":"Haiz"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":4,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2112897040"}